{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:31:19Z","timestamp":1791279079033,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CARCIN"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1093\/carcin\/bgt346","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:45:11Z","timestamp":1381884311000},"page":"86-95","source":"Crossref","is-referenced-by-count":32,"title":["Prognostic significance of KAI1\/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4"],"prefix":"10.1093","volume":"35","author":[{"given":"Yun","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Martinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher John","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,15]]},"reference":[{"key":"2015101507285022000_35.1.86.1","unstructured":"Jerant A.F. (2000) Early detection and treatment of skin cancer. Am. Fam. Physician, 62, 357\u201368, 375."},{"key":"2015101507285022000_35.1.86.2","doi-asserted-by":"crossref","unstructured":"Balch C.M. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol., 19, 3635\u20133648.","DOI":"10.1200\/JCO.2001.19.16.3635"},{"key":"2015101507285022000_35.1.86.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00161-7"},{"key":"2015101507285022000_35.1.86.4","doi-asserted-by":"publisher","DOI":"10.1080\/15398285.2012.701177"},{"key":"2015101507285022000_35.1.86.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.7754374"},{"key":"2015101507285022000_35.1.86.6","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90222-4"},{"key":"2015101507285022000_35.1.86.7","unstructured":"Guo C. (2009) Expression and clinical significance of p53, JunB and KAI1\/CD82 in human hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int, 8, 389\u2013396."},{"key":"2015101507285022000_35.1.86.8","doi-asserted-by":"publisher","DOI":"10.1038\/nature03452"},{"key":"2015101507285022000_35.1.86.9","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2763"},{"key":"2015101507285022000_35.1.86.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.168"},{"key":"2015101507285022000_35.1.86.11","unstructured":"Remmele W. (1987) [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe, 8, 138\u2013140."},{"key":"2015101507285022000_35.1.86.12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511309200"},{"key":"2015101507285022000_35.1.86.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.11.023"},{"key":"2015101507285022000_35.1.86.14","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.070772"},{"key":"2015101507285022000_35.1.86.15","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-0134"},{"key":"2015101507285022000_35.1.86.16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3444"},{"key":"2015101507285022000_35.1.86.17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4402"},{"key":"2015101507285022000_35.1.86.18","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgn086"},{"key":"2015101507285022000_35.1.86.19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3040"},{"key":"2015101507285022000_35.1.86.20","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.308"},{"key":"2015101507285022000_35.1.86.21","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200108061"},{"key":"2015101507285022000_35.1.86.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(02)00014-2"},{"key":"2015101507285022000_35.1.86.23","unstructured":"Guo X.Z. (2000) KAI1 gene is differently expressed in papillary and pancreatic cancer: influence on metastasis. World J. Gastroenterol., 6, 866\u2013871."},{"key":"2015101507285022000_35.1.86.24","unstructured":"R\u00f8tterud R. (2007) Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium. Histol. Histopathol., 22, 349\u2013363."},{"key":"2015101507285022000_35.1.86.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.11.001"},{"key":"2015101507285022000_35.1.86.26","unstructured":"Adachi M. (1996) Correlation of KAI1\/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res., 56, 1751\u20131755."},{"key":"2015101507285022000_35.1.86.27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.232637"},{"key":"2015101507285022000_35.1.86.28","doi-asserted-by":"publisher","DOI":"10.1159\/000134729"},{"key":"2015101507285022000_35.1.86.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2005.00062.x"},{"key":"2015101507285022000_35.1.86.30","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(11)60032-5"},{"key":"2015101507285022000_35.1.86.31","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<283::AID-PATH662>3.0.CO;2-3"},{"key":"2015101507285022000_35.1.86.32","unstructured":"Shiseki M. (2003) p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res., 63, 2373\u20132378."},{"key":"2015101507285022000_35.1.86.33","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.1532"},{"key":"2015101507285022000_35.1.86.34","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24748"},{"key":"2015101507285022000_35.1.86.35","unstructured":"Ono M. (1999) Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res., 59, 2335\u20132339."},{"key":"2015101507285022000_35.1.86.36","unstructured":"Lee J.H. (2003) Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res., 63, 7247\u20137255."},{"key":"2015101507285022000_35.1.86.37","unstructured":"Mannion B.A. (1996) Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d\/CD29). J. Immunol., 157, 2039\u20132047."},{"key":"2015101507285022000_35.1.86.38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M907971199"},{"key":"2015101507285022000_35.1.86.39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102156200"},{"key":"2015101507285022000_35.1.86.40","unstructured":"Yu Y. (1997) Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin. Cancer Res., 3, 1045\u20131049."},{"key":"2015101507285022000_35.1.86.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(97)00273-5"},{"key":"2015101507285022000_35.1.86.42","unstructured":"Tokuhara T. (2001) Clinical significance of CD151 gene expression in non-small cell lung cancer. Clin. Cancer Res., 7, 4109\u20134114."},{"key":"2015101507285022000_35.1.86.43","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.5801"},{"key":"2015101507285022000_35.1.86.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00809-7"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/35\/1\/86\/14132310\/bgt346.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T17:44:48Z","timestamp":1503423888000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgt346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,15]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,24]]},"published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1093\/carcin\/bgt346"],"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgt346","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,15]]}}}